DIA Europe 2019 has ended
avatar for Tatiana Reimer

Tatiana Reimer

Regulatory Affairs Strategist
Tatiana Anna Reimer is a Global Regulatory Strategist (GRS) at Bayer AG. As GRS, Tatiana is responsible for a regulatory strategy of development and marketed products in ophthalmic, haemophilia and pulmonary diseases. In addition, she is providing operational and strategic expertise in gene therapy development and is involved in Advance Therapy Medicinal Products EFPIA/EBE working group. Tatiana is a molecular biologist by training with PhD in cellular biology. She has more than 10 years of regulatory experience working first in small biotech (Jerini AG) on orphan disease later moving to European Medicines Agency as a trainee and paediatric coordinator and since 2009 she works as a regulatory affairs manager at Bayer.